1. A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Issue 5 (10th February 2023) Authors: Makker, Vicky; Aghajanian, Carol; Cohn, Allen L.; Romeo, Margarita; Bratos, Raquel; Brose, Marcia S.; Messing, Mark; Dutta, Lea; Dutcus, Corina E.; Huang, Jie; Schmidt, Emmett V.; Orlowski, Robert; Taylor, Matthew H. Journal: Journal of clinical oncology Issue: Volume 41:Issue 5(2023) Page Start: 974 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bevacizumab as front-line treatment for newly diagnosed epithelial cancer. Issue 2 (February 2013) Authors: González Martín, Antonio; Bratos, Raquel; Márquez, Raúl; Alonso, Sonsoles; Chiva, Luis Journal: Expert review of anticancer therapy Issue: Volume 13:Issue 2(2013) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP). (December 2020) Authors: Manso, Luis; Hernando, Cristina; Galán, María; Oliveira, Mafalda; Cabrera, Miguel A.; Bratos, Raquel; Rodríguez, César A.; Ruiz-Borrego, Manuel; Blanch, Salvador; Llombart-Cussac, Antonio; Delgado-Mingorance, Juan I.; Álvarez-Busto, Iñaki; Gallegos, Isabel; González-Cortijo, Lucía; Morales, Seraf... Journal: Breast Issue: Volume 54(2020) Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial. Issue 1 (January 2020) Authors: Prat, Aleix; Saura, Cristina; Pascual, Tomás; Hernando, Cristina; Muñoz, Montserrat; Paré, Laia; González Farré, Blanca; Fernández, Pedro L; Galván, Patricia; Chic, Núria; González Farré, Xavier; Oliveira, Mafalda; Gil-Gil, Miguel; Arumi, Miriam; Ferrer, Neus; Montaño, Alvaro; Izarzugaza, Yann; L... Journal: Lancet oncology Issue: Volume 21:Issue 1(2020) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Selective activity over a constitutively active RET‐variant of the oral multikinase inhibitor dovitinib: Results of the CNIO‐BR002 phase I‐trial. Issue 8 (17th July 2014) Authors: Quintela-Fandino, Miguel; Bueno, Maria J.; Lombardia, Luis; Gil, Marta; Gonzalez-Martin, Antonio; Marquez, Raul; Bratos, Raquel; Guerra, Juan; Tan, Eugene; Lopez, Antonio; Colomer, Ramon; Salazar, Ramon Journal: Molecular oncology Issue: Volume 8:Issue 8(2014:Dec.) Page Start: 1719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗